Harvard Gastroenterology Specialist Dr. Hamed Khalili Joins Vivante Health Advisory Board
Overview
- Company: Vivante Health
- Indication: Inflammatory Bowel Diseases
- Drug: N/A
- Trial Phase: N/A
- NCT ID: N/A
Details
Vivante Health has appointed Dr. Hamed Khalili to its Clinical Advisory Board to advance research in inflammatory bowel diseases. Dr. Khalili is a respected gastroenterologist at Massachusetts General Hospital and Associate Professor at Harvard Medical School, with a significant number of peer-reviewed publications.
Vivante Health specializes in digital solutions for digestive health, specifically through its platform GIThrive. It collaborates with healthcare providers to improve patient outcomes while reducing costs, particularly for chronic digestive disorders.
Dr. Khalili's expertise is expected to enhance Vivante Health's approach to the management of gut health and contribute to the company's continuous enhancements in digital health services.